Peter Maybarduk talks COVID-19 treatments on CounterSpin

By Janine Jackson

“We talk about seeing around the limitations of corporate media’s storyline when it comes to vaccines and treatments for Covid-19 with Peter Maybarduk; he’s director of the Global Access to Medicines Program at Public Citizen. They have a new report about the impact (so far) of Gilead’s monopoly control of the possible treatment drug Remdesivir.”

Listen to the interview here.